According to a study conducted by Zejun Jiang et al., AUCs for texture analysis‐based ML models of breast dynamic contrast enhancement‐magnetic resonance (DCE‐MR) images for predicting HER2 2+ patients with breast cancer ranged from 0.808 to 0.865.48 This evidence concerns the gene ERBB2 and breast cancer.